Viewing nowPoglo 5mg (Dapagliflozin Propanediol Monohydrate)
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

MFDS item code 202300404 · Approved 2023.01.31 · Insurance code 649808130
Effective in blood sugar control for type 2 diabetes and prevention of cardiovascular events
This medication is used in conjunction with dietary and exercise regimens to help control blood sugar levels in patients with type 2 diabetes. It can be used alone or in combination with other medications. It can also have an impact on patients with insufficient blood sugar control who are at risk of cardiovascular disease or have related risk factors. It is important to follow expert guidance when taking this medication. This medication is effective for the treatment of type 2 diabetes.
The recommended dose of this medication for monotherapy and as an adjunct to insulin or other antihyperglycemic agents is 10 mg once daily. For initial combination therapy, it is either 5 mg once daily or 10 mg once daily. There are separate dosage adjustment recommendations based on renal impairment, liver impairment, and elderly patients. This medication can be taken orally at any time of day regardless of food intake, and the tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in patients under the age of 18 have not been established. There is no related data available.
This medication should not be used in certain patients. Individuals with allergies to the active ingredient or excipients, patients with type 1 diabetes, those with diabetic ketoacidosis, lactose intolerance, genetic metabolic disorders, and patients undergoing dialysis should not take this medication. Patients with decreased fluid volume or impaired renal function should use this medication cautiously. This medication may lower blood pressure or reduce intravascular fluid volume, leading to risks of hypotension or acute kidney injury. Patients with reduced renal function, elderly patients, and those taking diuretics should exercise more caution, and blood pressure and renal function should be carefully monitored before and after administration. Adverse reactions that may occur when taking this medication include genital infections, urinary tract infections, hypoglycemia, dehydration, diabetic ketoacidosis, and various other abnormalities. Particularly, genital infections may be more common in women and those with a history of past infections, so if any infection symptoms occur, it is essential to consult healthcare professionals immediately. Additionally, this medication may induce diabetic ketoacidosis, so even if blood sugar levels are within normal range, if symptoms of ketoacidosis appear, prompt testing and treatment are necessary. Elderly patients or those with compromised liver function should also be cautious when using this medication and should regularly monitor fluid status and blood pressure changes. This medication may increase the risk of hypoglycemia when used in combination with hypoglycemic agents such as insulin or sulfonylurea, thus dose adjustments of such medications may be necessary. It is recommended that women who are pregnant or breastfeeding do not use this medication and if pregnancy is confirmed, they should stop taking it immediately. The safety and effectiveness of this medication for pediatric patients have not been established, and there is no related data available. In case of overdose, there is no specific antidote available, so it is crucial to receive treatment according to the symptoms and follow healthcare professionals' instructions. Finally, this medication does not significantly affect the ability to drive or operate machinery; however, caution is advised for combined use with other medications due to the risk of hypoglycemia.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/conjunctival mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, vision abnormalities, numbness, urination
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to store the medication at room temperature between 1°C and 30°C. This way, the medication's effectiveness and safety can be maintained.
Yellow, biconvex, round film-coated tablet
30 tablets/bottle, 90 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.